Bilim VN - Search Results

1

Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2.

Ougolkov AV, Bilim VN, Billadeau DD. Ougolkov AV, et al. Among authors: bilim vn. Clin Cancer Res. 2008 Nov 1;14(21):6790-6. doi: 10.1158/1078-0432.CCR-08-1013. Clin Cancer Res. 2008. PMID: 18980972 Free PMC article.

2

Altered expression of beta-catenin and c-erbB-2 in early gastric cancer.

Ougolkov A, Mai M, Takahashi Y, Omote K, Bilim V, Shimizu A, Minamoto T. Ougolkov A, et al. J Exp Clin Cancer Res. 2000 Sep;19(3):349-55. J Exp Clin Cancer Res. 2000. PMID: 11144528

3

Abnormal expression of E-cadherin, beta-catenin, and c-erbB-2 in advanced gastric cancer: its association with liver metastasis.

Ougolkov A, Yamashita K, Bilim V, Takahashi Y, Mai M, Minamoto T. Ougolkov A, et al. Int J Colorectal Dis. 2003 Mar;18(2):160-6. doi: 10.1007/s00384-002-0427-2. Epub 2002 Aug 10. Int J Colorectal Dis. 2003. PMID: 12548420

4

Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer.

Ougolkov A, Zhang B, Yamashita K, Bilim V, Mai M, Fuchs SY, Minamoto T. Ougolkov A, et al. J Natl Cancer Inst. 2004 Aug 4;96(15):1161-70. doi: 10.1093/jnci/djh219. J Natl Cancer Inst. 2004. PMID: 15292388

5

Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.

Ougolkov AV, Fernandez-Zapico ME, Bilim VN, Smyrk TC, Chari ST, Billadeau DD. Ougolkov AV, et al. Among authors: bilim vn. Clin Cancer Res. 2006 Sep 1;12(17):5074-81. doi: 10.1158/1078-0432.CCR-06-0196. Clin Cancer Res. 2006. PMID: 16951223 Free PMC article.

6

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma.

Bilim V, Ougolkov A, Yuuki K, Naito S, Kawazoe H, Muto A, Oya M, Billadeau D, Motoyama T, Tomita Y. Bilim V, et al. Br J Cancer. 2009 Dec 15;101(12):2005-14. doi: 10.1038/sj.bjc.6605437. Epub 2009 Nov 17. Br J Cancer. 2009. PMID: 19920820 Free PMC article.

7

Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer.

Naito S, Bilim V, Yuuki K, Ugolkov A, Motoyama T, Nagaoka A, Kato T, Tomita Y. Naito S, et al. Clin Cancer Res. 2010 Nov 1;16(21):5124-32. doi: 10.1158/1078-0432.CCR-10-0275. Epub 2010 Oct 1. Clin Cancer Res. 2010. PMID: 20889919

8

The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells.

Sakurai T, Bilim VN, Ugolkov AV, Yuuki K, Tsukigi M, Motoyama T, Tomita Y. Sakurai T, et al. Among authors: bilim vn. Biochem Biophys Res Commun. 2012 Jun 15;422(4):607-14. doi: 10.1016/j.bbrc.2012.05.035. Epub 2012 May 15. Biochem Biophys Res Commun. 2012. PMID: 22609199 Free article.

9

Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.

Hara N, Kasahara T, Kawasaki T, Bilim V, Obara K, Takahashi K, Tomita Y. Hara N, et al. Clin Cancer Res. 2002 Jun;8(6):1794-9. Clin Cancer Res. 2002. PMID: 12060619 Clinical Trial.

10

Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β.

Tsukigi M, Bilim V, Yuuki K, Ugolkov A, Naito S, Nagaoka A, Kato T, Motoyama T, Tomita Y. Tsukigi M, et al. Cancer Lett. 2012 Feb 28;315(2):189-97. doi: 10.1016/j.canlet.2011.10.008. Epub 2011 Oct 10. Cancer Lett. 2012. PMID: 22093618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters